Drucker M H, Vanek V W, Franco A A, Hanson M, Woods L
Surg Neurol. 1984 Nov;22(5):444-8. doi: 10.1016/0090-3019(84)90300-8.
Ventriculoatrial shunts were first developed in the 1940s and shortly thereafter became the treatment of choice for noncommunicating hydrocephalus. Although the mortality rate for noncommunicating hydrocephalus has fallen from 80% to 20%, ventriculoatrial shunts continue to have major life-threatening complications such as thromboemboli, infection, and shunt malfunction. This report presents the cases of two adult hydrocephalic patients who developed pulmonary emboli and sepsis after being treated with ventriculoatrial shunts. One patient, whose complications were not recognized until late in the course, died of pulmonary hypertension and right heart failure despite removal of the shunt and aggressive medical therapy. Complications in the second patient were discovered early, the shunt was removed, and intravenous antibiotics were used for weeks to combat sepsis and bacterial endocarditis.
脑室心房分流术最早于20世纪40年代研发出来,此后不久便成为治疗非交通性脑积水的首选方法。尽管非交通性脑积水的死亡率已从80%降至20%,但脑室心房分流术仍存在血栓栓塞、感染和分流故障等严重危及生命的并发症。本报告介绍了两名成年脑积水患者的病例,他们在接受脑室心房分流术治疗后出现了肺栓塞和败血症。一名患者在病程后期才被发现并发症,尽管移除了分流装置并进行了积极的药物治疗,但仍死于肺动脉高压和右心衰竭。第二名患者的并发症被早期发现,移除了分流装置,并使用静脉抗生素数周以对抗败血症和细菌性心内膜炎。